Omeprazole inhibits nocturnal and pentagastrin-stimulated gastric secretion in Man
- 31 August 1984
- journal article
- research article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 29 (9) , 797-801
- https://doi.org/10.1007/bf01318421
Abstract
The effect of omeprazole on the overnight and pentagastrin-stimulated gastric secretion of acid and pepsin have been studied in healthy male volunteers. After treatment with omeprazole, 30 mg or 60 mg daily for one week, overnight secretion of acid was reduced by 48 and 73%, respectively. During stimulation with pentagastrin, a single dose of 40 mg omeprazole reduced acid output by 98%, while after 80 mg, secretion of acid and pepsin was completely abolished. Omeprazole is one of the most potent gastric secretory inhibitors available at present, with potential for use in the therapy of ulcer disease.Keywords
This publication has 7 references indexed in Scilit:
- Effect of daily oral omeprazole on 24 hour intragastric acidity.BMJ, 1983
- RAPID HEALING OF DUODENAL ULCERS WITH OMEPRAZOLE: DOUBLE-BLIND DOSE-COMPARATIVE TRIALThe Lancet, 1983
- [Behavior of acid secretion under the long-term daily administration of omeprazol].1983
- Effect of omeprazole--a gastric proton pump inhibitor--on pentagastrin stimulated acid secretion in man.Gut, 1983
- Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+ + K+) ATPaseNature, 1981
- INHIBITION OF PENTAGASTRIN-STIMULATED AND NOCTURNAL GASTRIC SECRETION BY RANITIDINEThe Lancet, 1979
- A Modified Hemoglobin Substrate Method for the Estimation of Pepsin in Gastric JuiceScandinavian Journal of Gastroenterology, 1970